Font Size: Decrease Font Size Increase Font Size

Interactive Satellite:

New Frontiers in NIH AIDS Research

Sunday, July 22, 11:15 a.m.-1:15 p.m., Session Room 6

Watch the webcast of this session!

Tremendous progress has been made in HIV prevention and treatment research in recent years, but we remain far from declaring victory against AIDS. What are some of the key AIDS research challenges before us? How is NIH working to develop and improve upon the most effective HIV prevention and treatment tools, including:

    • Better methods to prevent and treat HIV-associated coinfections, malignancies, and complications
    • Improved biomedical and behavioral prevention tools, including microbicides and vaccines
    • Strategies to understand the factors that affect HIV vulnerability, treatment outcomes, and disease progression among different populations
    • New treatment and prevention strategies for substance users
    • Approaches to overcome drug resistance and treatment failure and eradicate persistent HIV viral reservoirs that may one day lead to a cure for HIV disease.


Dr. Francis CollinsDirector, National Institutes of Health
Dr. Anthony S. FauciDirector, National Institute of Allergy and Infectious Diseases
Dr. Jack WhitescarverDirector, Office of AIDS Research
Dr. Nora VolkowDirector, National Institute on Drug Abuse
Dr. Carl DieffenbachDirector, Division of AIDS, National Institute of Allergy and Infectious Diseases
Dr. Avindra NathIntramural Clinical Director, National Institute of Neurological Disorders and Stroke
Dr. Robert YarchoanDirector, Office of HIV and AIDS Malignancy, National Cancer Institute
Dr. Basil EldadahActing Chief, Geriatrics Branch, National Institute on Aging
Dr. Bill KapogiannisMedical Officer, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Dr. Gina BrownNIH Office of AIDS Research
Dr. Victoria CargillNIH Office of AIDS Research
Mark HarringtonExecutive Director, Treatment Action Group